| 摘要 |
PURPOSE: To obtain a preparation containing the cells (their treated products) of a lactic acid bacterium as an active ingredient, free from a side effect and toxicity, and enabling the rapid therapy of chronic active C type hepatitis by the oral administration of the preparation. CONSTITUTION: The preparation contains the cells of a lactic acid bacterium or their treated products, preferably comprising the cells of a microorganism [e.g. Enterococcus faecalis NF-1011 (FERM P-12564)] belonging to the genus Enterococcus, as an active ingredient. For the production of the preparation, a carrier such as starch, lactose or soybean protein, and additives such as an excipient, a binder, a disintegrator, a lubricant, a stabilizer and a flavor are used. The preparation is usually administered at a dose of 2-100mg/kg body weight/day as the active ingredient in one to several portions. The preparation can be used together with other medicines, and is effective also for a patient not exhibiting an effect on an INF therapeutic method. |
